SE0301577L - Lösning med låg natriumhalt - Google Patents

Lösning med låg natriumhalt

Info

Publication number
SE0301577L
SE0301577L SE0301577A SE0301577A SE0301577L SE 0301577 L SE0301577 L SE 0301577L SE 0301577 A SE0301577 A SE 0301577A SE 0301577 A SE0301577 A SE 0301577A SE 0301577 L SE0301577 L SE 0301577L
Authority
SE
Sweden
Prior art keywords
solution
sodium solution
low sodium
dialysis
concentration
Prior art date
Application number
SE0301577A
Other languages
English (en)
Swedish (sv)
Other versions
SE0301577D0 (sv
Inventor
Anders Wieslander
Ola Carlsson
Pascal Bernard
Per Ulinder
Original Assignee
Gambro Lundia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro Lundia Ab filed Critical Gambro Lundia Ab
Priority to SE0301577A priority Critical patent/SE0301577L/xx
Publication of SE0301577D0 publication Critical patent/SE0301577D0/xx
Priority to CA2524094A priority patent/CA2524094C/fr
Priority to PCT/SE2004/000754 priority patent/WO2004105730A1/fr
Priority to EP04733508A priority patent/EP1626705A1/fr
Priority to EP15180762.5A priority patent/EP2962683A1/fr
Priority to CA2820174A priority patent/CA2820174C/fr
Publication of SE0301577L publication Critical patent/SE0301577L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0301577A 2003-05-28 2003-05-28 Lösning med låg natriumhalt SE0301577L (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0301577A SE0301577L (sv) 2003-05-28 2003-05-28 Lösning med låg natriumhalt
CA2524094A CA2524094C (fr) 2003-05-28 2004-05-17 Solution a faible teneur en sodium
PCT/SE2004/000754 WO2004105730A1 (fr) 2003-05-28 2004-05-17 Solution a faible teneur en sodium
EP04733508A EP1626705A1 (fr) 2003-05-28 2004-05-17 Solution a faible teneur en sodium
EP15180762.5A EP2962683A1 (fr) 2003-05-28 2004-05-17 Solution à faible teneur en sodium
CA2820174A CA2820174C (fr) 2003-05-28 2004-05-17 Solution a faible teneur en sodium offrant differentes concentrations en sodium destinee a la dialyse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301577A SE0301577L (sv) 2003-05-28 2003-05-28 Lösning med låg natriumhalt

Publications (2)

Publication Number Publication Date
SE0301577D0 SE0301577D0 (sv) 2003-05-28
SE0301577L true SE0301577L (sv) 2004-11-29

Family

ID=20291448

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301577A SE0301577L (sv) 2003-05-28 2003-05-28 Lösning med låg natriumhalt

Country Status (4)

Country Link
EP (2) EP1626705A1 (fr)
CA (2) CA2820174C (fr)
SE (1) SE0301577L (fr)
WO (1) WO2004105730A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8202248B2 (en) 2004-08-18 2012-06-19 Sequana Medical Ag Dialysis implant and methods of use
US9039652B2 (en) 2011-02-16 2015-05-26 Sequana Medical Ag Apparatus and methods for treating intracorporeal fluid accumulation
US8585635B2 (en) 2012-02-15 2013-11-19 Sequana Medical Ag Systems and methods for treating chronic liver failure based on peritoneal dialysis
EP3452139B1 (fr) 2016-05-06 2023-08-30 Gambro Lundia AB Système de dosage de fluides
JP7034933B2 (ja) 2016-05-06 2022-03-14 ガンブロ・ルンディア・エービー 透析濃縮液
JP7071338B2 (ja) 2016-08-26 2022-05-18 セクアナ メディカル エヌブイ 埋め込み型装置によって生成されたデータを管理及び分析するためのシステム及び方法
US10716922B2 (en) 2016-08-26 2020-07-21 Sequana Medical Nv Implantable fluid management system having clog resistant catheters, and methods of using same
US10918778B2 (en) * 2017-05-24 2021-02-16 Sequana Medical Nv Direct sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients
US11559618B2 (en) 2017-05-24 2023-01-24 Sequana Medical Nv Formulations and methods for direct sodium removal in patients having severe renal dysfunction
WO2024008684A1 (fr) 2022-07-08 2024-01-11 Zytoprotec Gmbh Fluide pour dialyse péritonéale

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103395D0 (sv) 1991-11-18 1991-11-18 Gambro Ab System med anvaendning av ensteril medicinsk loesning innehaallande glukos eller glukosliknande aemnen samt en loesning avsedd foer detta system
US5589197A (en) * 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution
SE510030C2 (sv) * 1995-08-08 1999-04-12 Gambro Ab Förfarande för blandning av steril medicinsk lösning samt behållare för utförande av förfarandet
US6399110B1 (en) 1997-08-22 2002-06-04 Shimizu Pharmaceutical Co., Ltd. Glucose-containing preparation
DE19748290B8 (de) * 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
SE512349C2 (sv) 1997-11-28 2000-03-06 Gambro Lundia Ab Flerkammarbehållare för medicinsk lösning, förfarnde för beredning av medicinsk lösning för peritonealdialys samt användning av sådan behållare vid beredning av medicinsk lösning
DE69929550T8 (de) 1998-05-21 2006-12-28 Nipro Corp. Albumin enthaltende Lösung für die Peritonealdialyse
DE19912850B4 (de) * 1999-03-22 2005-04-07 Fresenius Medical Care Deutschland Gmbh Lösung, insbesondere für Hämo- oder Peritonealdialyse, sowie Verfahren zu deren Herstellung
US6309673B1 (en) * 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy

Also Published As

Publication number Publication date
EP2962683A1 (fr) 2016-01-06
EP1626705A1 (fr) 2006-02-22
CA2524094A1 (fr) 2004-12-09
WO2004105730A1 (fr) 2004-12-09
CA2820174C (fr) 2018-12-11
SE0301577D0 (sv) 2003-05-28
CA2524094C (fr) 2014-03-25
CA2820174A1 (fr) 2004-12-09

Similar Documents

Publication Publication Date Title
SG169228A1 (en) Biocompatible dialysis fluids containing icodextrins
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
MEP36608A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
NZ544801A (en) Antiseptic compositions, methods and systems
JO2449B1 (en) Thiosol derivatives - benziazothiazole dioxide, methods of preparation and use.
MY137477A (en) Substituted oxazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
BR0318185A (pt) composição para administração de ferro para o tratamento de sìndrome das pernas inquietas
BR0014820A (pt) Solução de diálise incluindo agente osmótico de poliglicol, e seu uso
SE0301577D0 (sv) Low sodium solution
IL143824A0 (en) New dialysis method
DE602004016950D1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
IL179012A0 (en) Method and composition for treating rhinitis
TW200616985A (en) Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use
UA83888C2 (ru) Фармацевтическая композиция винфлунина, предназначенная для парентерального введения, способ получения и применение
SE0402507D0 (sv) Medicinsk lösning, förfarande för framställning och användning därav
ATE482705T1 (de) Antibakterielle behandlung von osteoarthritis
WO2005049483A3 (fr) Composes chlores reactifs, leurs derives, anions et sels, procedes pour les produire et leur utilisation
EP1622450A4 (fr) Procede destine a favoriser un sommeil ininterrompu par l'administration d'un chlorure de trospium
ATE547111T1 (de) Methode zur herstellung eines transfer faktor medikaments
BRPI0411524A (pt) formulação farmacêutica de amoxicilina e clavulanato, uso de carboximetilcelulose de sódio, e, método de tratar infecção bacteriana em pacientes pediátricos
DE602004028234D1 (de) Biokompatibles polymer
TW200503999A (en) Therapeutic agents
PT1791422E (pt) Processo de esterilização para a produção de material biológico implantável ou transplantável
RU2004116284A (ru) Способ обработки костной полости после некрсеквестрэктомии

Legal Events

Date Code Title Description
NAV Patent application has lapsed